VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U7526AA: VAERS reports

45 VAERS reports list lot U7526AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2022-06-27 and 2024-06-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
45
Reports
0%
Marked serious
0
With a death outcome
19
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2267%
General / Systemic (non-local)39%
Neurological26%
Allergic / Anaphylactic26%
Dermatological (non-injection-site)26%
Gastrointestinal13%
Psychiatric / Neuropsychiatric13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan5
California5
Florida3
Texas3
Kansas3
Kentucky3
Massachusetts2
New Jersey2
Pennsylvania2
Arizona2
New York2
Virginia1

Reports by month received

2022-061
2022-073
2022-083
2022-093
2022-101
2022-114
2022-124
2023-011
2023-024
2023-034
2023-043
2023-051
2023-061
2023-071
2023-082
2023-093
2023-103
2023-122
2024-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.